Viropro Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2006
2007
2008
2009
2010
Cash & Short Term Investments
97.40
40.00
2.70
54.80
58.90
Total Accounts Receivable
3.60
21.40
2.40
-
103.90
Other Current Assets
435.40
263.90
124.40
4.90
10.00
Total Current Assets
536.40
325.30
129.60
59.60
172.80
Net Property, Plant & Equipment
17.20
13.40
-
2.20
57.60
Total Investments and Advances
52.00
-
-
-
-
Long-Term Note Receivable
-
-
-
-
13.00
Intangible Assets
957.40
852.40
-
-
1,877.50
Other Assets
-
-
-
-
5.60
Total Assets
1,562.90
1,191.00
129.60
61.90
2,126.50
ST Debt & Current Portion LT Debt
-
-
692.20
100.00
175.60
Accounts Payable
164.10
753.80
324.50
130.40
461.10
Other Current Liabilities
347.00
60.60
80.00
200.00
20.40
Total Current Liabilities
511.10
814.50
1,096.70
430.40
657.10
Long-Term Debt
547.40
647.80
485.60
-
-
Total Liabilities
1,058.50
1,462.20
1,582.30
430.40
657.10
Common Equity (Total)
504.40
271.20
1,452.70
368.60
1,469.50
Total Shareholders' Equity
504.40
271.20
1,452.70
368.60
1,469.50
Total Equity
504.40
271.20
1,452.70
368.60
1,469.50
Liabilities & Shareholders' Equity
1,562.90
1,191.00
129.60
61.90
2,126.50

About Viropro

View Profile
Address
2151 O'Toole Avenue
San Jose California 95131
United States
Employees -
Website http://www.viropro.net
Updated 07/08/2019
Operates as a biopharmaceutical company .